tiprankstipranks
Trending News
More News >
333D Limited (AU:T3D)
ASX:T3D
Australian Market

333D Limited (T3D) AI Stock Analysis

Compare
4 Followers

Top Page

AU:T3D

333D Limited

(Sydney:T3D)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 5.2)
Rating:42Neutral
Price Target:
AU$0.03
▼(-6.67% Downside)
Action:ReiteratedDate:02/10/26
The score is held down primarily by balance-sheet fragility (negative equity) and a history of volatile earnings/cash flow despite a strong FY2025 rebound. Technicals add further pressure with a weak trend and bearish momentum. Valuation is also demanding (high P/E), limiting upside unless the turnaround proves durable.
Positive Factors
FY2025 revenue and margin rebound
The ~60% revenue increase and return to ~14% net margin in FY2025 indicate meaningful operational recovery and renewed demand traction. A sustained uplift in top-line and margin expansion supports durable earnings potential and provides a basis for reinvesting in product and sales capabilities over the next several quarters.
Positive operating and free cash flow
Moving from cash burn to positive operating and free cash flow (~$70.7k) demonstrates improved cash conversion and operational discipline. Even modest positive cash flow reduces immediate financing pressure, aids working capital management, and gives management a firmer platform to sustain operations and smaller investments without relying solely on external capital.
Low reported financial leverage
The absence of reported debt across FY2022–FY2025 lowers fixed financing costs and reduces default risk. Low leverage gives flexibility to manage through cyclical swings, preserves interest capacity for future strategic moves, and provides a cleaner starting point for restructuring the capital base if needed.
Negative Factors
Negative shareholders' equity
Negative shareholders' equity reflects accumulated losses and a thin capital base, materially weakening solvency. This elevates refinancing and dilution risk, constrains the company's ability to absorb future setbacks, and can limit access to institutional financing or favorable supplier terms over the medium term.
Historic earnings and cash-flow volatility
A history of persistent losses and volatile cash flows undermines predictability of future performance. Even with the FY2025 rebound, volatility raises execution risk for scaling operations, makes budgeting and capital allocation harder, and increases the probability that achieved margins may revert during adverse cycles.
Modest absolute cash generation
Reported free cash flow (~$70.7k) is positive but modest and showed a decline versus the prior period, highlighting limited internal funding capacity. This constrains investment in growth, R&D, or working capital and increases the likelihood the company will need external capital if it seeks to scale or withstand another downcycle.

333D Limited (T3D) vs. iShares MSCI Australia ETF (EWA)

333D Limited Business Overview & Revenue Model

Company Description333D Limited, together with its subsidiaries, provides 3D printing services in Australia. The company offers 3D printing equipment and consumables; and sells 3D prints. 333D Limited was incorporated in 2006 and is based in Laverton North, Australia.
How the Company Makes Money333D Limited generates revenue primarily through the sale of 3D printed products and services. The company offers customized 3D printing solutions to various sectors, enabling clients to create prototypes, models, and finished goods. Additionally, 333D Limited may engage in partnerships with other businesses to expand its market reach and enhance its product offerings. The company could also explore opportunities in licensing its technology or collaborating on research and development initiatives to further drive its revenue streams. However, specific details about significant partnerships or additional revenue factors are currently unavailable.

333D Limited Financial Statement Overview

Summary
FY2025 shows a strong rebound (revenue up ~60%, return to positive net profit with ~14% margin, and positive operating/free cash flow). However, multi-year profitability and cash-flow volatility plus negative shareholders’ equity in FY2025 materially elevate risk and reduce confidence in durability.
Income Statement
53
Neutral
The latest annual period (FY2025) shows a sharp rebound with revenue up ~60% and a return to positive net profit (~14% margin), supported by a healthier gross margin (~40%). However, profitability has been highly volatile: FY2020–FY2024 featured persistent losses and, in several years, deeply negative margins, which raises questions around earnings durability and the consistency of the underlying business model.
Balance Sheet
28
Negative
Leverage is currently low (total debt reported at zero in FY2022–FY2025), which reduces financial risk. The key weakness is solvency: shareholders’ equity is negative in FY2025 (and was materially negative across several prior years), implying accumulated losses and a thin capital base. Total assets increased in FY2025, but negative equity limits balance-sheet flexibility and can increase refinancing/raising-capital risk if performance weakens.
Cash Flow
41
Neutral
Cash generation improved in FY2025 with positive operating and free cash flow (~$70.7k), a meaningful step up from cash burn in FY2022–FY2024. That said, cash flow has been inconsistent year-to-year (including sizable outflows in FY2023 and FY2022), and FY2025 free cash flow declined versus the prior period on the provided growth metric. Overall, cash flow is improving but not yet stable enough to be viewed as structurally strong.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue1.11M1.01M190.31K23.95K63.68K114.97K
Gross Profit540.53K403.08K181.29K-146.37K-209.88K-24.78K
EBITDA-182.13K144.81K-600.60K-836.10K-1.22M-488.88K
Net Income8.97K143.78K-506.61K-724.97K-1.24M-338.79K
Balance Sheet
Total Assets1.12M641.11K24.68K89.29K441.52K132.40K
Cash, Cash Equivalents and Short-Term Investments736.33K75.27K4.58K65.05K415.73K99.21K
Total Debt0.000.000.000.000.00300.00K
Total Liabilities385.73K686.08K553.85K505.88K365.68K678.88K
Stockholders Equity735.03K-44.96K-529.17K-416.60K75.84K-546.47K
Cash Flow
Free Cash Flow424.93K70.68K-60.46K-350.69K-195.78K90.04K
Operating Cash Flow424.93K70.68K-60.46K-350.69K-195.78K90.04K
Investing Cash Flow-370.50K0.000.000.000.000.00
Financing Cash Flow629.57K0.000.000.00512.30K0.00

333D Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
61
Neutral
AU$2.95M1.10%34.27%
42
Neutral
AU$5.84M145.00426.44%
37
Underperform
AU$1.43M-0.37
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:T3D
333D Limited
0.03
0.02
107.14%
AU:1TT
Wooboard Technologies Limited
0.01
0.00
0.00%
AU:CT1
Constellation Technologies Limited

333D Limited Corporate Events

333D Flags Material Impairment in Bitcoin Treasury Holdings
Feb 2, 2026

333D Limited has reported that the market value of its Bitcoin treasury holdings stood at $228,838 as at 1 February 2026, representing an impairment of $141,661, or 13.6% of the consolidated group’s total assets, thereby triggering its continuous disclosure obligations under ASX Listing Rule 3.1. The company attributed the decline in the Australian dollar value of its Bitcoin position to a combination of cryptocurrency price volatility and a strengthening Australian dollar against the US dollar, and noted that it does not currently hedge its cryptocurrency or foreign exchange exposures, meaning investors should expect ongoing variability in reported valuations as part of its broader digital asset treasury strategy.

The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D posts sixth straight quarter of revenue growth and advances blockchain healthcare push
Jan 30, 2026

333D Limited reported its sixth consecutive quarter of growth in cash receipts, generating $330,917 from digital asset management contracts in the December quarter, reflecting a 3.92% increase and underscoring the success of its strategic pivot into healthcare-focused digital asset management. The company recorded net operating cash outflows of $99,180 on quarterly expenditure of about $430,097, ended the period with combined cash and Bitcoin holdings of $993,691, and highlighted progress in its BioScan 360 collaboration, having successfully stored full body MRI scan data on the blockchain with plans to scale this decentralised, patient-controlled data solution across the preventative healthcare market.

The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D Limited Announces Director’s Acquisition of Performance Rights
Dec 9, 2025

333D Limited has announced a change in the director’s interest, specifically involving Dr. Richard Petty, who has acquired 1,000,000 performance rights as part of the company’s Long Term Incentive Plan. This acquisition was made without cash consideration, indicating a strategic move to align the director’s interests with the company’s long-term goals, potentially impacting the company’s governance and stakeholder confidence.

333D Limited Updates Director’s Interest with New Incentives
Dec 9, 2025

333D Limited has announced a change in the director’s interest, specifically involving Dr. Nigel Finch. The change involves the acquisition of 750,000 performance rights by Saki Partners (Services) Pty Ltd, a company controlled by Dr. Finch, as part of the company’s Long Term Incentive Plan. This move increases the total performance rights held by Saki Partners to 2,250,000, reflecting the company’s strategy to incentivize its leadership.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 10, 2026